#	Pagina
attuale pagina	/open-h2020/projects/211551/index.html
-1	/open-h2020/projects/209272/index.html
-2	/open-h2020/projects/201216/index.html

Opendata, web and dolomites

ZEBRAONCOFISH SIGNED

Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

ZEBRAONCOFISH project word cloud

Explore the words cloud of the ZEBRAONCOFISH project. It provides you a very rough idea of what is the project "ZEBRAONCOFISH" about.

disease actionable estimations effect leader 425 personalized platform carry metabolic profile approx presented acquired therapy made thanks decisions biological individual remarkable directed vivo dynamic solution found cancerous tailor lab hospitals time deaths genetic roadmap subjacent people ultimate transplant human biotechnological lines biology differently mechanism patient chance display progression opportunity understand zebraoncofish living therapeutic zebrafish healthcare solutions mortality cell 35 influence treatment interventions tumor created company extensive anticancer mean million interspecies commercialization team guide underlying tubes difficulty assays onset complete morbidity avatars samples xenotransplantation tax makeup drugs market performed treatments complexity cancer close

Project "ZEBRAONCOFISH" data sheet

The following table provides information about the project.

Coordinator	IKAN BIOTECH S.L. Organization address address: CALLE CHAPITELA 20 1 city: PAMPLONA postcode: 31001 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Project website	http://zebraoncofish.com/
Total cost	2˙004˙583 €
EC max contribution	2˙004˙583 € (100%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-2-2016-2017
Funding Scheme	SME-2
Starting year	2017
Duration (year-month-day)	from 2017-09-01 to 2020-05-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	IKAN BIOTECH S.L. IKAN BIOTECH S.L. Organization address address: CALLE CHAPITELA 20 1 city: PAMPLONA postcode: 31001 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (PAMPLONA)	coordinator	2˙004˙583.00

Map

Project objective

The Zebrafish Lab is a biotechnological company leader in the development and commercialization of novel, tailor-made solutions based on in vivo zebrafish assays. Thanks to the extensive knowledge acquired by the R&D projects performed in the field by our team for many years and a close collaboration with Hospitals and Cancer Research Institutions, we have identified a remarkable opportunity in the ZEBRAONCOFISH project that will mean a 5-year after tax-R.O.I of 425% according to our estimations. The ultimate goal of the project presented as ZEBRAONCOFISH is to complete the technical roadmap required to bring to the healthcare market a novel real time in vivo platform for personalized cancer treatment based on the use of zebrafish “avatars” as personalized, living test tubes. Cancer is a leading cause of morbidity and mortality with approx. 35 million people affected by this disease and more than 8 million deaths per year. A major difficulty found in effective cancer treatment is the complexity of the biological mechanism underlying cancer onset and disease progression. This is because the genetic makeup and metabolic profile of each individual patient influence the effect of anticancer drugs. As such, different people respond differently to the same therapy. The solution we propose in the ZEBRAONCOFISH project is the use of zebrafish avatars as an in vivo platform to guide therapeutic decisions in actionable cancer patient-directed interventions. These avatars will be created by xenotransplantation (interspecies transplant) of human cancer cell lines/ tumor samples in zebrafish. The chance to carry out a dynamic display of the cancerous process in vivo will offer the unique opportunity to understand the subjacent cancer biology and design tailor-made treatments for each patient.

Deliverables

List of deliverables.
ZEBRAONCOFISH webpage	Websites, patent fillings, videos etc.	2020-04-24 04:18:30

Take a look to the deliverables list in detail: detailed list of ZEBRAONCOFISH deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2018	Letrado P, de Miguel I, Lamberto I, DÃez-MartÃnez R, Oyarzabal J. Zebrafish: Speeding up the Cancer Drug Discovery Process. published pages: , ISSN: 0008-5472, DOI:	Cancer Research	2020-04-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ZEBRAONCOFISH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ZEBRAONCOFISH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination